Alzheimer’s Research Team Wins $25 Million to Help It Compete for 2018 XPRIZE

Alzheimer’s Research Team Wins $25 Million to Help It Compete for 2018 XPRIZE
The founders of Edelman Financial Services have donated $25 million to a group called the Alzheimer’s Disease Team to help it compete for a global XPRIZE. Jean and Ric Edelman announced the donation at the 2017 XPRIZE Visioneers Summit in Los Angeles on Oct. 19. The Alzheimer's team, which received the highest score at the summit, advances to the global XPRIZE 2018 competition. XPRIZE is a non-profit organization founded in 1995 whose goal is to marshal crowdsourcing, philanthropic donations and other funding sources to tackle the world's greatest challenges. Its fund-raising format is designed to greatly increase the amount that would normally be available for a project. Two hundred fifty prominent people rated the proposals of the Alzheimer's Disease Team and four other teams seeking an XPRIZE. The other proposals dealt with clean air, cybersecurity, democracy, and industrial waste. The Alzheimer’s team received the highest score. The raters included prominent corporate and political leaders, entrepreneurs, philanthropists, artists, technologists, and scientists. Dr. Ken Dychtwald, founder and CEO of Age Wave, and XPRIZE's founder, Dr. Peter Diamandis, came up with the idea of an XPRIZE competition for Alzheimer's in November 2012. The Edelmans joined the effort shortly thereafter. Dychtwald created an Alzheimer’s team composed of more than 100 leading neuroscientists, advocates and technology experts to develop a proposal for the competition. The hope is that an XPRIZE will lead to ways to detect and diagnose Alzheimer’s early, and eventually a cure. The Alzheimer’s Disease Team plans to use cutting-edge technologies, including big data
Subscribe or to access all post and page content.

One comment

  1. Janet Bright says:

    I was intrigued by the radio broadcast and want to revisit it. Is there a transcript? I was especially interested in postmortem brain studies of infants with alzheimer’s but couldn’t find that online.
    The science logic you outlined was very interesting. So many loopholes in medicine. Especially the lack of wholism or collaboration between specialists. Afterall, we are one. Please continue to educate, inspire and push for a more open minded and expansive view for this disease and thought process by which we think and live.
    I have some college science and would love to work along side of you. Let me know if you know of a part time job in the Bay Area.

Leave a Comment

Your email address will not be published. Required fields are marked *